May 03, 2021 / 12:30PM GMT
Operator
Good morning. My name is Jason, and I will be your conference operator today. At this time, I'd like to welcome everyone to the Karyopharm Therapeutics First Quarter 2021 Financial Results conference call. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company's request.
I would now like to turn the call over to Mr. Ian Karp, Karyopharm's Senior Vice President, Investor and Public Relations.
Ian Karp - Karyopharm Therapeutics Inc. - SVP of Investor & Public Relations
Great. Thank you, and thank you all for joining us on today's conference call to discuss Karyopharm's First Quarter Financial Results and Business Update. And let me be the first one to officially welcome our new President and Chief Executive Officer; Mr. Richard Paulson to our quarterly earnings call. This is Ian Karp, and today, in addition to both Michael Kauffman and Richard Paulson, I'm also joined by Mr. Mike Mason, our Chief Financial Officer; Mr. John Demaree, Chief Commercial Officer; and Mr. Stephen Mitchener,
Q1 2021 Karyopharm Therapeutics Inc Earnings Call Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers